MAGNAWAVE Trademark

Trademark Overview

On Wednesday, January 27, 2021, a trademark application was filed for MAGNAWAVE with the United States Patent and Trademark Office. The USPTO has given the MAGNAWAVE trademark a serial number of 90493025. The federal status of this trademark filing is REGISTERED as of Tuesday, May 7, 2024. This trademark is owned by Magna Wave, Inc.. The MAGNAWAVE trademark is filed in the Medical Instrument Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Veterinary services, namely, inflammation reduction, pain relief, improved blood oxygenation and blood flow; Health care services, namely, inflammation reduction, pain relief, improved blood oxygenation and blood flow

Electromedical rehabilitative and pain management products for business, home and animal use, namely, electrical nerve and muscle stimulators and magnet therapy stimulators for inflammation reduction, pain relief, improved blood oxygenation and blood flow; Apparatus for magnet therapy, namely, for inflammation reduction, pain relief, improved blood oxygenation and blood flow
magnawave

General Information

Serial Number90493025
Word MarkMAGNAWAVE
Filing DateWednesday, January 27, 2021
Status700 - REGISTERED
Status DateTuesday, May 7, 2024
Registration Number7381103
Registration DateTuesday, May 7, 2024
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements

Description of MarkThe mark consists of the word "MAGNAWAVE" in stylized characters.
Pseudo MarkMAGNA WAVE
Goods and ServicesVeterinary services, namely, inflammation reduction, pain relief, improved blood oxygenation and blood flow; Health care services, namely, inflammation reduction, pain relief, improved blood oxygenation and blood flow
Goods and ServicesElectromedical rehabilitative and pain management products for business, home and animal use, namely, electrical nerve and muscle stimulators and magnet therapy stimulators for inflammation reduction, pain relief, improved blood oxygenation and blood flow; Apparatus for magnet therapy, namely, for inflammation reduction, pain relief, improved blood oxygenation and blood flow

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, April 29, 2021
Primary Code010
First Use Anywhere DateMonday, December 23, 2019
First Use In Commerce DateMonday, December 23, 2019
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 18, 2022
Primary Code044
First Use Anywhere DateMonday, December 23, 2019
First Use In Commerce DateMonday, December 23, 2019

Trademark Owner History

Party NameMagna Wave, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLouisville, KY 40299
Party NameMagna Wave, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLouisville, KY 40299
Party NameMagna Wave, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLouisville, KY 40299

Trademark Events

Event DateEvent Description
Thursday, April 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 30, 2021NEW APPLICATION ENTERED
Friday, June 11, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, June 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 11, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 13, 2021ASSIGNED TO EXAMINER
Tuesday, August 24, 2021NON-FINAL ACTION WRITTEN
Tuesday, August 24, 2021NON-FINAL ACTION E-MAILED
Tuesday, August 24, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 17, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 17, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 8, 2022FINAL REFUSAL WRITTEN
Friday, April 8, 2022FINAL REFUSAL E-MAILED
Friday, April 8, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, October 6, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, October 6, 2022EXPARTE APPEAL RECEIVED AT TTAB
Thursday, October 6, 2022JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, October 6, 2022EX PARTE APPEAL-INSTITUTED
Tuesday, November 15, 2022ASSIGNED TO LIE
Tuesday, November 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 28, 2022EXPARTE APPEAL TERMINATED
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 19, 2023ASSIGNED TO EXAMINER
Wednesday, August 23, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 23, 2023SOU EXTENSION 1 FILED
Wednesday, August 23, 2023SOU EXTENSION 1 GRANTED
Friday, August 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 28, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, February 28, 2024USE AMENDMENT FILED
Wednesday, February 28, 2024SOU TEAS EXTENSION RECEIVED
Thursday, March 21, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 21, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 2, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, April 1, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 7, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 7, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

magnawave blood pain relief flow improved oxygenation reduction namely inflammation therapy